ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $51,000 | -21.5% | 8,538 | 0.0% | 0.00% | – |
Q3 2019 | $65,000 | -54.5% | 8,538 | -18.2% | 0.00% | -100.0% |
Q2 2019 | $143,000 | +130.6% | 10,433 | -8.3% | 0.00% | – |
Q1 2019 | $62,000 | +181.8% | 11,383 | +58.9% | 0.00% | – |
Q4 2018 | $22,000 | -65.6% | 7,163 | -8.0% | 0.00% | -100.0% |
Q3 2018 | $64,000 | -15.8% | 7,788 | -11.1% | 0.00% | 0.0% |
Q2 2018 | $76,000 | 0.0% | 8,765 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $76,000 | -30.9% | 8,765 | -0.7% | 0.00% | 0.0% |
Q4 2017 | $110,000 | +48.6% | 8,824 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $74,000 | +289.5% | 8,824 | +669.3% | 0.00% | – |
Q2 2017 | $19,000 | -24.0% | 1,147 | -8.8% | 0.00% | – |
Q1 2017 | $25,000 | +1150.0% | 1,258 | +1158.0% | 0.00% | – |
Q4 2016 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q3 2015 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 507,191 | $5,107,000 | 0.50% |
Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |